CBLL
CeriBell, Inc
NASDAQ: CBLL · HEALTHCARE · MEDICAL DEVICES
$17.73
-0.56% today
Updated 2026-07-29
Market cap
$617.71M
P/E ratio
—
P/S ratio
6.50x
EPS (TTM)
$-1.57
Dividend yield
—
52W range
$11 – $24
Volume
0.3M
CeriBell, Inc (CBLL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$17.73
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.1B | $0.1B |
| EPS | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -63.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.